Revenue: The sum of all revenue fields included for a company's operating activities.
BioNTech SE Sponsored ADR (BNTX) had Revenue of $296.06M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$296.06M |
$-438.87M |
|
$86.73M |
|
$209.33M |
|
$864.91M |
|
$-568.85M |
|
$111.70M |
|
$-457.15M |
|
$-457.15M |
|
$-438.87M |
|
$-438.87M |
|
$-438.87M |
|
$-438.87M |
|
$-568.85M |
|
$-507.46M |
|
241.62M |
|
241.62M |
|
$-1.82 |
|
$-1.82 |
|
| Balance Sheet Financials | |
$18.08B |
|
$1.16B |
|
$6.48B |
|
$24.56B |
|
$2.10B |
|
$246.57M |
|
$1.45B |
|
$3.56B |
|
$21.01B |
|
$18.91B |
|
$21.01B |
|
240.40M |
|
| Cash Flow Statement Financials | |
$-719.94M |
|
$1.34B |
|
$-30.76M |
|
$11.08B |
|
$11.66B |
|
$576.23M |
|
$44.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.61 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
70.71% |
|
-192.14% |
|
-192.14% |
|
-- |
|
-154.41% |
|
-148.24% |
|
$-805.08M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.33 |
|
0.18 |
|
496.24 |
|
-2.09% |
|
-2.32% |
|
-1.79% |
|
-2.06% |
|
$87.38 |
|
$-3.33 |
|
$-2.98 |
|